NASDAQ: CDIO
Cardio Diagnostics Holdings Inc Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their CDIO stock forecasts and price targets.

Forecast return on equity

Is CDIO forecast to generate an efficient return?

Forecast return on assets

Is CDIO forecast to generate an efficient return on assets?

CDIO revenue forecast

What is CDIO's revenue in the next 1 years based on estimates from 3 analysts?

Avg 1 year Forecast
$25.5M+161,476.48%

CDIO vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CDIO$1.29N/AN/A
REVB$1.65N/AN/A
JAGX$0.67N/AN/A
PPCB$0.19N/AN/A
AZTR$0.21N/AN/A

Cardio Diagnostics Holdings Stock Forecast FAQ

What is CDIO's revenue growth forecast for 2026-2026?

(NASDAQ: CDIO) Cardio Diagnostics Holdings's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of N/A.

Cardio Diagnostics Holdings's revenue in 2026 is $15,782.

In 2026, CDIO is forecast to generate $46,564,301 in revenue, with the lowest revenue forecast at $44,738,250 and the highest revenue forecast at $47,933,839.

If you're new to stock investing, here's how to buy Cardio Diagnostics Holdings stock.

What is CDIO's forecast return on assets (ROA) for 2026-2026?

(NASDAQ: CDIO) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 12.6%.

What is CDIO's forecast return on equity (ROE) for 2026-2026?

(NASDAQ: CDIO) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.